These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6488438)

  • 1. Synergistic antitumor activity of vincristine and VP-16-213.
    Jackson DV; Long TR; Trahey TF; Morgan TM
    Cancer Chemother Pharmacol; 1984; 13(3):176-80. PubMed ID: 6488438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination vincristine and VP-16-213: evaluation of drug sequence.
    Jackson DV; Long TR; Rice DG; Morgan TM
    Cancer Biochem Biophys; 1986 Oct; 8(4):265-75. PubMed ID: 3802048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
    Slater LM; Murray SL; Wetzel MW; Sweet P; Stupecky M
    Cancer Chemother Pharmacol; 1986; 16(1):50-4. PubMed ID: 3455667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.
    Shinoda H; Ebisu H; Mitsuhashi J; Inaba M; Tsuruo T
    Cancer Chemother Pharmacol; 1992; 30(5):335-40. PubMed ID: 1505070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of potentiation of vincristine-induced neurotoxicity by VP-16-213.
    Jackson DV; Wells HB; White DR; Muss HB; Richards F; Cooper MR; Stuart JJ; Pope EK; Spurr CL
    Am J Clin Oncol; 1983 Jun; 6(3):327-30. PubMed ID: 6303106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effects of a podophyllotoxin derivative, VP 16-213].
    Morita M; Haji A; Goto A; Hattori N; Hasegawa Y
    Nihon Yakurigaku Zasshi; 1986 Jan; 87(1):53-66. PubMed ID: 3957154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents.
    Dorr RT; Alberts DS
    Invest New Drugs; 1983; 1(2):151-9. PubMed ID: 6678864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker.
    Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y
    Cancer Treat Rep; 1985 May; 69(5):523-5. PubMed ID: 4005874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A phase II clinical trial of oral VP 16-213 in advanced non-Hodgkin's lymphoma].
    Nakada H; Ogawa M; Ingaki J; Horikoshi N; Inoue K; Usui N; Adachi K; Tada A; Yamazaki H; Mukaiyama T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1644-8. PubMed ID: 6476837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of resistance to vincristine in P388 leukemia by various polycyclic clinical drugs, with a special emphasis on quinacrine.
    Inaba M; Maruyama E
    Cancer Res; 1988 Apr; 48(8):2064-7. PubMed ID: 3349478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T; Nagahata T; Arakawa M; Ekimoto H; Takahashi K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
    Jackson DV; Zekan PJ; Caldwell RD; Slatkoff ML; Harding RW; Case LD; Hopkins JO; Muss HB; Richards F; White DR
    J Clin Oncol; 1984 Dec; 2(12):1343-51. PubMed ID: 6096517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias.
    Ganu UK; Khandalekar DD; Gokhale SV
    Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic synergy of trimetrexate (CI-898) in combination with doxorubicin, vincristine, cytoxan, 6-thioguanine, cisplatin, or 5-fluorouracil against intraperitoneally implanted P388 leukemia.
    Leopold WR; Dykes DJ; Griswold DP
    NCI Monogr; 1987; (5):99-104. PubMed ID: 2963231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
    Athanassiades P; Bacoyiannes H; Kontoyiannes D
    Chemioterapia; 1986 Apr; 5(2):125-7. PubMed ID: 3518965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VP-16 in combinations for first-line treatment of malignant germ-cell tumors and gestational choriocarcinoma.
    Newlands ES
    Semin Oncol; 1985 Mar; 12(1 Suppl 2):37-41. PubMed ID: 2579442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of etoposide with cisplatin or cyclophosphamide in the treatment of mouse Lewis lung carcinoma].
    Uchida T; Okamoto K; Nishikawa K; Takahashi K
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):75-9. PubMed ID: 3753643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effects of human recombinant interleukin-1 alpha and etoposide against human tumor cells: mechanism for synergism in vitro and activity in vivo.
    Usui N; Matsushima K; Pilaro AM; Longo DL; Wiltrout RH
    Biotherapy; 1996; 9(4):199-208. PubMed ID: 9012539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
    Kiue A; Sano T; Naito A; Okumura M; Kohno K; Kuwano M
    Br J Cancer; 1991 Aug; 64(2):221-6. PubMed ID: 1892749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.